Fresh2 (FRES) Stock Analysis
NASDAQHealthcareBiotechnology
What Fresh2 does
Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
Key metrics
ETFs linked to FRES
Broad-market and Healthcare sector ETFs an investor holding Fresh2 is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how FRES fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze FRES in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Fresh2?
- Fresh2 trades under the ticker FRES on NASDAQ.
- Which exchange is FRES listed on?
- FRES is listed on NASDAQ.
- What sector does Fresh2 operate in?
- Fresh2 is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze FRES in a portfolio?
- PortView shows FRES's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.